Product Images Dutasteride

This is a report on randomized double-blind, placebo-controlled trials pooled to study the percent of subjects who underwent surgery for benign prostatic hyperplasia over a 24-month period. The report provides data on the percentage of patients who received treatment over a 6 to 24 months period, cumulative numbers of patients, and the number of events in the placebo and dutasteride groups at different times.*

The text describes a figure showing the percent change in prostate volume from baseline in a pool of randomized, double-blind, placebo-controlled trials. The x-axis shows the duration of treatment in months, while the y-axis shows the mean percent change from baseline. The figure includes data for both placebo and dutasteride groups.*

This appears to be a table showing the mean change from baseline in milliliters per second (mL/sec) for a treatment over a certain number of months. The treatment options are listed as "Placebo" and "Dutasteride," with the number of participants for each group listed next to the treatment name. The text may be a part of a larger study or clinical trial report.*

The text is a table showing the mean change in IPSS (International Prostate Symptom Score) after treatment with Dutasteride and Tamsulosin for a certain number of months. The table includes the number of participants in each group. Therefore, this text provides data on the efficacy of the treatment for prostate symptoms.*

This appears to be a chart or graph showing the mean change from baseline in mL/sec over a period of 24 months of treatment. Three groups are shown: one group receiving Dutasteride and tamsulosin (n=1477), one group receiving Dutasteride alone (n=1483), and one group receiving Tamsulosin alone (n=1510), with the dosage specified for each. The chart includes labeled time intervals in months.*

This appears to be a description of a medication named "Dutasteride Capsules" manufactured by "Cai Heathcare Ltd" and distributed by "Viona Pharmaceuticals". There are warnings against women and children using it and instructions to swallow the capsules whole without chewing or opening them. The usual dosage mentioned is 0.5 mg once a day, along with storage instructions. There is no information on what the medication is used for.*